Home » Topics » BioWorld Science

BioWorld Science
RSS

Soligenix obtains support to study IDRs as bacterial threat countermeasures

May 29, 2019

Enrollment opens in phase III study of HLX-10 in esophageal squamous cell carcinoma

May 29, 2019

SNG-001 for virus-induced exacerbations of lung disease

May 29, 2019

Food antigens drive IgE antibody elevation if no commensals present

May 29, 2019

In infection, T cells are cachexia drivers

May 29, 2019

"R-AI-diologist" can outperform radiologists in lung cancer screening

May 29, 2019

TLRs in DIO

May 29, 2019

Glial dysfunction is part of chemo brain

May 29, 2019

Calidi collaborates with NIH to study therapeutic potential of oncolytic viruses delivered by MSCs

May 28, 2019

Phase III cohort of valoctocogene roxaparvovec meets criteria for regulatory review

May 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...